Medindia » Consumer Health » Health Information » Cardiac Markers - About

Cardiac Markers-Types- Indications-Cardiac Marker genes –Research-FAQs

About Cardiac Markers

RSS Feeds   Text 
Cardio vascular disease (CVD) is a leading cause of morbidity and mortality. Most of the deaths occur even before a patient reaches the hospital for treatment. Cardiac markers are biomarkers which are measured to evaluate the function of heart.


A number of conditions can lead to an elevation in cardiac marker level, the most important one being myocardial infarction (MI), commonly known as a heart attack. Many of the markers are enzymes; the term "cardiac enzymes" is sometimes used. However, not all the markers are enzymes. Troponin for example is not an enzyme in formal terms.

Aspartate Amino transferase was perhaps the first biochemical marker to be used; it was described in 1954. With the advent of electrophoresis method walked in Creatine Kinase and Lactate Dehydrogenase iso enzymes. The use of cTnT brought about a revolution in 1992. The introduction of Cardiac troponins heralded a new age in the diagnosis and treatment or management of a broad spectrum of diseases.


Share it!
Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.
Posted by:  Randox  Posted on: 11/15/2010
The ischemic biomarker Heart-type Fatty Acid Binding Protein [H-FABP] can substantially improve the detection of high risk patients when Troponin-negative, even when a high sensitivity assay is used, a new publication has shown. In the June edition of JACC, Professor Alistair Hall and colleagues from the University of Leeds, UK, prospectively studied a cohort of 1080 consecutive patients admitted to hospital with suspected ACS and compared the H-FABP assay (Randox Laboratories) with the high sensitivity Ultra-TnI assay (Siemens Healthcare Diagnostics).




X
Related Links
Increased Risk of Cancer and Death With Biological Aging Markers
New Blood Markers Identified to Determine Heart Attack
Study Explores Ways to Prevent Death from Sudden Cardiac Arrest During Sleep
Link Between Genetic Variant, Risk of Coronary Artery Disease Disproved by Stanford-led Study
Potential New Heart Attack Biomarker Identified
Citing this Health Article
The information on Medindia is factual, unbiased and authentic. If you find the content useful - PLEASE INCLUDE A LINK TO THIS PAGE.

Highlight the text, right-click, and select “copy”. Paste the link into your website, email, or any other HTML document.

News on Cardiac Markers
* Effect of Socioeconomic Factors on Myocardial Infarction Outcomes
* High Blood Homocysteine Levels and Coronary Heart Disease, Not Linked
* Rivaroxaban Plus Standard Antiplatelet Therapy Improves Survival After Myocardial Infarction
* More on Optimal Reperfusion in ST-Elevation Myocardial Infarction
* Angiotensin Receptor Blockers Reduce the Risk of Myocardial Infarction
Total News Item 13
Are you a member of Facebook? Become a fan of Medindia and get breaking news delivered to your Facebook page.